MADRIGAL PHARMACEUTICALS, INC. (MDGL) Executive Compensation
MADRIGAL PHARMACEUTICALS, INC. (MDGL) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MDGL
CIK: 1157601
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerChristopher Hudson
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 144 | 2026-09-28 | — | 144 Filing | 0001950047-26-009840 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-09 | FORM 4 | 0001628280-26-061581 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001950047-26-009360 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001628280-26-061190 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-17 | FORM 4 | 0001628280-26-058256 | View SEC Doc Filr Page |
| 144 | 2026-08-20 | — | 144 Filing | 0001628280-26-058254 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | FORM 4 | 0001628280-26-057751 | View SEC Doc Filr Page |
| 3 | 2026-08-18 | 2026-08-11 | FORM 3 | 0001628280-26-057747 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-11 | 8-K | 0001628280-26-055962 | View SEC Doc Filr Page |
| 10-Q | 2026-07-30 | 2026-06-30 | 10-Q | 0001628280-26-050845 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001628280-26-050775 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-29 | — | SCHEDULE 13G/A Filing | 0002012383-26-002902 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-17 | FORM 4 | 0001628280-26-048919 | View SEC Doc Filr Page |
| 144 | 2026-07-20 | — | 144 Filing | 0001628280-26-048913 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | FORM 4 | 0001628280-26-044346 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | FORM 4 | 0001628280-26-044340 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | FORM 4 | 0001628280-26-044325 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | FORM 4 | 0001628280-26-044307 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | FORM 4 | 0001628280-26-044290 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | 4 | 0001193125-26-275800 | View SEC Doc Filr Page |
| S-8 | 2026-06-17 | — | FORM S-8 | 0001104659-26-075183 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-16 | FORM 8-K | 0001104659-26-075130 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-06-01 | FORM 4 | 0001628280-26-039653 | View SEC Doc Filr Page |
| 144 | 2026-06-01 | — | 144 Filing | 0001950047-26-005407 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-22 | FORM 4 | 0001628280-26-037830 | View SEC Doc Filr Page |